Emerging Proximal Liquid Biopsy Approaches for Detecting Residual Disease and Predicting Recurrence in Head and Neck Cancer: A Review and Proposal of Novel Liquid Staging
Open Access
- 21 March 2025
- journal article
- review article
- Published by Wiley in Head & Neck
- Vol. 47 (6) , 1779-1787
Abstract
Background: Head and neck squamous cell carcinoma remains challenging due to high recurrence rates and poor survival outcomes. Developing precise technologies for disease burden assessment, treatment response, and minimal residual disease (MRD) surveillance is crucial for improving prognosis. Methods: This review explores the potential of liquid biopsy for MRD and recurrence detection. A novel liquid TNM (LiTNM) staging system is introduced, integrating biomarkers from saliva, surgical drain lymphatic fluid (SLF), and peripheral blood. Results: Proximal liquid biopsies, particularly saliva and SLF, offer advantages due to their proximity to the tumor microenvironment. Saliva demonstrates high sensitivity in HPV‐associated oropharyngeal cancers, while SLF holds potential in identifying early postoperative recurrence. Despite these advancements, standardization and validation remain challenges. Conclusions: Liquid biopsy approaches show promise for postoperative disease monitoring, yet their clinical implementation remains in the early stages. The proposed LiTNM staging system could complement TNM staging by providing a molecular framework for risk stratification. However, rigorous prospective studies are necessary to validate its clinical utility and facilitate adoption.Keywords
This publication has 86 references indexed in Scilit:
- Circulating Tumor HPV DNA for Surveillance of HPV-Positive Oropharyngeal Squamous Cell CarcinomaJAMA Oncology, 2023
- Performance of Liquid Biopsy for Diagnosis and Surveillance of Human Papillomavirus–Associated Oropharyngeal CancerJAMA Otolaryngology–Head & Neck Surgery, 2023
- Development and validation of a novel TNM staging N‐classification of oral cavity squamous cell carcinomaCancer, 2023
- Blood and saliva‐derived ctDNA is a marker of residual disease after treatment and correlates with recurrence in human papillomavirus‐associated head and neck cancerCancer Medicine, 2023
- Patterns of recurrence in head and neck squamous cell carcinoma to inform personalized surveillance protocolsCancer, 2023
- Decline in circulating viral and human tumor markers after resection of head and neck carcinomaHead & Neck, 2020
- Association of Oral Human Papillomavirus DNA Persistence With Cancer Progression After Primary Treatment for Oral Cavity and Oropharyngeal Squamous Cell CarcinomaJAMA Oncology, 2019
- Association of Oral Cavity and Oropharyngeal Cancer Biomarkers in Surgical Drain Fluid With Patient OutcomesJAMA Otolaryngology–Head & Neck Surgery, 2017
- Saliva and Plasma Quantitative Polymerase Chain Reaction–Based Detection and Surveillance of Human Papillomavirus–Related Head and Neck CancerJAMA Otolaryngology–Head & Neck Surgery, 2014
- Matrix metalloproteases in head and neck cancerHead & Neck, 2006